Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Ivan A. Moiseev"'
Autor:
Chantal Lucini, Klára Obrová, Isabella Krickl, Filomena Nogueira, Iva Kocmanová, Susanne Herndlhofer, Karoline V. Gleixner, Wolfgang R. Sperr, Tijana Frank, Nuno Andrade, Christina Peters, Gernot Engstler, Michael Dworzak, Andishe Attarbaschi, Martine van Grotel, Marry M. van den Heuvel-Eibrink, Ivan S Moiseev, Yuliya Rogacheva, Ludmilla Zubarovskaya, Natalia Zubarovskaya, Herbert Pichler, Anita Lawitschka, Elisabeth Koller, Felix Keil, Jiří Mayer, Barbora Weinbergerová, Peter Valent, Thomas Lion
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-6 (2024)
Abstract Invasive fungal disease (IFD) presents a life-threatening condition in immunocompromised patients, thus often prompting empirical administration of antifungal treatment, without adequate mycological evidence. Over the past years, wide use of
Externí odkaz:
https://doaj.org/article/c7e9e4e77a8c4a348f7597f39ffc6c98
Autor:
Kseniia S. Afanaseva, Evgeny A. Bakin, Anna G. Smirnova, Ildar M. Barkhatov, Tatiana L. Gindina, Ivan S. Moiseev, Sergey N. Bondarenko
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract The posttransplant relapse in Ph-positive ALL increases the risk of death. There is an unmet need for instruments to predict the risk of relapse and plan prophylaxis. In this study, we analyzed posttransplant data by machine learning algorit
Externí odkaz:
https://doaj.org/article/fe1c772ed7094f7ea37ffbd37c5092b5
Autor:
Oleg V. Goloshchapov, Alexey B. Chukhlovin, Dmitrii E. Polev, Yury A. Eismont, Dmitry S. Bug, Alexey V. Kusakin, Oleg V. Kosarev, Ruslana V. Klementeva, Vladimir V. Gostev, Vladimir A. Ageevets, Nikita P. Volkov, Anastasia S. Ipatova, Ivan S. Moiseev, Anna A. Spiridonova, Sergey V. Sidorenko, Alexander D. Kulagin
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1566 (2024)
Dose-intensive cytostatic therapy and antibiotic treatment in allogeneic hematopoietic stem cell transplantation (allo-HSCT) cause severe abnormalities in a composition of gut microbiota as well as the emergence of antibiotic resistance. The data on
Externí odkaz:
https://doaj.org/article/615f785603d64f08b1735b6cc021750c
Autor:
Alexey Yu. Polushin, Iaroslav B. Skiba, Evgeny A. Bakin, Maria D. Vladovskaya, Victoria A. Yakovleva, Ivan S. Moiseev, Stanislav N. Yanishevskiy, Igor A. Voznyuk, Alexander D. Kulagin
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 17, Iss 1, Pp 27-35 (2023)
Introduction. Modern transplantation and biological therapy methods are associated with a wide range of adverse events and complications. Incidence and variety of neurological complications mostly depend on myelo- and immunosuppression severity and d
Externí odkaz:
https://doaj.org/article/41c4d2d708cb4d6483acad1c366b6dcc
Autor:
Alexey Yu. Polushin, Iaroslav B. Skiba, Evgeny A. Bakin, Maria D. Vladovskaya, Ivan S. Moiseev, Igor A. Voznyuk, Alexander D. Kulagin
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 16, Iss 2, Pp 36-43 (2022)
Introduction. More than 50,000 haematopoietic stem cell transplantations (HSCTs) are performed worldwide each year to treat malignant blood cancers, solid tumours, bone marrow aplasia, primary immunodeficiency conditions, autoimmune disorders, and st
Externí odkaz:
https://doaj.org/article/f759c3260f2340ee8150762acb5b2cfd
Publikováno v:
Current Issues in Molecular Biology, Vol 43, Iss 2, Pp 605-617 (2021)
Untranslated gene regions (UTRs) play an important role in controlling gene expression. 3′-UTRs are primarily targeted by microRNA (miRNA) molecules that form complex gene regulatory networks. Cancer genomes are replete with non-coding mutations, m
Externí odkaz:
https://doaj.org/article/7bd3b98a8ed8483f8f191944aeca0776
Autor:
Oleg V. Goloshchapov, Evgenii I. Olekhnovich, Sergey V. Sidorenko, Ivan S. Moiseev, Maxim A. Kucher, Dmitry E. Fedorov, Alexander V. Pavlenko, Alexander I. Manolov, Vladimir V. Gostev, Vladimir A. Veselovsky, Ksenia M. Klimina, Elena S. Kostryukova, Evgeny A. Bakin, Alexander N. Shvetcov, Elvira D. Gumbatova, Ruslana V. Klementeva, Alexander A. Shcherbakov, Margarita V. Gorchakova, Juan José Egozcue, Vera Pawlowsky-Glahn, Maria A. Suvorova, Alexey B. Chukhlovin, Vadim M. Govorun, Elena N. Ilina, Boris V. Afanasyev
Publikováno v:
BMC Microbiology, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Fecal microbiota transplantation (FMT) has been recently approved by FDA for the treatment of refractory recurrent clostridial colitis (rCDI). Success of FTM in treatment of rCDI led to a number of studies investigating the effect
Externí odkaz:
https://doaj.org/article/78f30b949a854bfb94166405a8166d93
Autor:
Ivan Sergeevich Moiseev, Nikolay Yurevich Tcvetkov, Ildar Munerovich Barkhatov, Maria Vladimirovna Barabanshikova, Dmitrii Sergeevich Bug, Natalya Vitalievna Petuhova, Artem Valerievich Tishkov, Evgenyi Alexandrovich Bakin, Ekaterina Andreevna Izmailova, Alena Igorevna Shakirova, Alexandr Dmitrievich Kulagin, Elena Vladislavovna Morozova
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248430 (2021)
A number of sequencing studies identified the prognostic impact of somatic mutations in myelodysplastic syndrome (MDS). However the majority of them focused on methylation regulation, apoptosis and proliferation genes. Despite the number of experimen
Externí odkaz:
https://doaj.org/article/28e62eeb8eee4b4d81e100826feb3c57
Autor:
Kirill V. Lepik, Liudmila V. Fedorova, Elena V. Kondakova, Yuri R. Zalyalov, Elena V. Babenko, Elena E. Lepik, Polina V. Kotselyabina, Anastasia V. Beynarovich, Marina O. Popova, Nikita P. Volkov, Lilia V. Stelmakh, Vadim V. Baykov, Ivan S. Moiseev, Natalia B. Mikhailova, Alexander D. Kulagin, Boris V. Afanasyev
Publikováno v:
HemaSphere, Vol 4, Iss 5, p e480 (2020)
Abstract. The introduction of nivolumab has changed the landscape of relapsed/refractory classical Hodgkin lymphoma (r/r cHL) treatment. Despite its clinical importance, this therapy may remain inaccessible for a significant number of patients worldw
Externí odkaz:
https://doaj.org/article/26c4ae48c6e54f8491d5fcf760d55f6c
Autor:
Kirill V. Lepik, Natalia B. Mikhailova, Elena V. Kondakova, Yuri R. Zalyalov, Liudmila V. Fedorova, Luibov A. Tsvetkova, Polina V. Kotselyabina, Evgeniya S. Borzenkova, Elena V. Babenko, Marina O. Popova, Elena I. Darskaya, Vadim V. Baykov, Ivan S. Moiseev, Boris V. Afanasyev
Publikováno v:
HemaSphere, Vol 4, Iss 3, p e401 (2020)
Abstract. This single-center prospective clinical trial evaluated the combination of nivolumab plus bendamustine (NB) as a salvage regimen in classical Hodgkin lymphoma patients after failure of nivolumab monotherapy. A total of 30 patients received
Externí odkaz:
https://doaj.org/article/4007f47d8ed2482b85babff63061e790